Abstract
The incidence of systemic Candida infections in patients requiring intensive care has increased substantially in recent years as a result of a combination of factors. More patients with severe underlying disease or immunosuppression from anti-neoplastic or anti-rejection chemotherapy and at risk from fungal infection are now admitted to the ICU. Improvements in supportive medical and surgical care have led to many patients who would previously have died as a result of trauma or disease surviving to receive intensive care. Moreover, some therapeutic interventions used in the ICU, most notably broad-spectrum antibiotics and intravascular catheters, are also associated with increased risks of candidiasis. Systemic Candida infections are associated with a high morbidity and mortality, but remain difficult to diagnose and ICU staff need to bé acutely aware of this often insidious pathogen. A number of studies have identified risk factors for systemic Candida infection which may be used to identify those at highest risk. Such patients may be potential candidates for early, presumptive therapy. Here we review the epidemiology, pathogenesis, morbidity and mortality of systemic Candida infections in the ICU setting, and examine predisposing risk factors. Antifungal treatment, including the use of amphotericin B, flucytosine and fluconazole, and the roles of early presumptive therapy and prophylaxis, is also reviewed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91 (Suppl 3B): 72S-75S
Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29 (Suppl A): 19–24
Beck-Sagué C, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 167: 1247–1251
Bodey GP (1993) Hematogenous and major organ candidiasis. In: Bodey GP (ed) Candidiasis: Pathogenesis, diagnosis and treatment. Raven Press, New York, pp 279–329
Franklin C, Metry M (1992) Life-threatening Candida infections in the intensive care unit. J Intensive Care Med 7: 127–137
Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T et al. (1991) Secular trends in nosocomial primary bloodstream infections in the United States. Am J Med 91 (Suppl 3B): 86S-89S
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128–140
Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoine M-H, Wolff M, Spencer RC, Hemmer MD (1995) The prevalence of nosocomial infection in intensive care units in Europe (EPIC). JAMA 274: 639–644
Brooks RG (1989) Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 149: 2226–2228
Menezes AV, Sigesmund DA, Demajo WA, Devenyi RG (1994) Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med 154: 2093–2097
Horn R, Wong B, Kiehn TE, Armstrong D (1985) Fungemia in a cancer hospital: changing frequency, earlier onset and results of therapy. Rev Infect Dis 7: 646–655
Wey SB, Motomi M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148:2642–2645
Bross J, Talbot GH, Maislin G, Hurwits S, Strom BL (1989) Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 87: 614–620
Pittet D (1993) Nosocomial bloodstream infections. In: Wenzel RP (ed) Prevention and Control of Nosocomial Infections, 2nd Edn. Williams and Wilkins, Baltimore, pp 512–555
Edwards JE Jr (1990) Candida species. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice of infectious disease, 3rd Edn. Churchill Livingstone, New York, pp 1943–1958
Odds FC (1988) Candida and candidosis. Balliére Tindall, London
Hoeprich PD, Rinaldi MG (1989) Candidosis. In: Hoeprich PD, Jordan MC (eds) Infectious diseases, a modern treatise of infectious processes. Lippincott, Philadelphia, pp 465–481
Rotstein O, Pruett T, Simmons R (1986) Microbiologic features and treatment of persistent peritonitis in patients in the intensive care unit. Can J Surg 29:247–250
Marshall J, Christou N, Norn R, Meakins J (1988) The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 123: 309–315
Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR (1991) Risk factors of candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 13: 211–215
Pittet D, Monod M, Filthuth I, Frenk E, Suter PM, Auckenthaler R (1991) Contour-clamped homogenous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 91 (Suppl 3B): 256S-263S
Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN (1994) Investigation of the sequence of colonization and candidemia in non-neutropenic patients. J Clin Microbiol 32: 975–980
Solomkin JS (1993) Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. New Horizons 1: 202–213
Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751–758
Alexander J, Gianotti L, Pyles T, Carey M, Babcock G (1991) Distribution of Escherichia coli translocating from the intestine after thermal injury. Ann Surg 213:558–567
Deitch EA, Bridges W, Baker J, Ma JW, Ma L, Grisham MB, Granger DN, Specian RD, Berg R (1988) Hemorrhagic shock induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 104:191–198
Alverdy J (1991) The effect of glucocorticoid administration on bacterial translocation. Evidence for an aquired mucosal immunodeficient state. Ann Surg 214:719–723
Langer JC, Sohal SS (1992) Increased mucosal permeability after intestinal ischemia-reperfusion injury is mediated by local tissue factors. J Pediatr Surg 27:239–241
Salzman AL, Wollert PS, Wang H, Menconi MJ, Youssef ME, Compton CC, Fink MP (1993) Intraluminal oxygenation ameliorates ischaemia/reperfusion-induced gut mucosal hyperpermeability in pigs. Circ Shock 40: 37–46
Gianotti L, Alexander J, Fukushima R, Childress C (1993) Translocation of Candida albicans is related to the blood flow of individual intestinal villi. Circ Shock 40: 250–257
Spaeth G, Gottwald T, Specian RD, Mainous MR, Berg RD, Deitch EA (1994) Secretory immunoglobulin A, intestinal mucin and mucosal permeability in nutritionally induced bacterial translocation in rats. Ann Surg 220: 798–808
Sganga G, Gangeri G, Montemagno S, Castagneto M (1995) Prevention of translocation — prevention of multiple organ system failure. In: Mutz NJ, Koller W, and Benzer H (eds) Proceedings of the 7th European Congress on Intensive Care Medicine, Innsbruck, Austria, June 14–17 1994. Monduzzi Editore S.p. A., Bologna, pp 93–101
33. Burnie JP, Odds FC, Lee W, Webster C, Williams JD (1985) Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. BMJ 290: 746–748
Vaudry WL, Tierney AJ, Wenman WM (1988) Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis 158:1375–1379
Matthews R, Burnie J (1989) Assessment of DNA fingerprinting for rapid identification of outbreaks of systemic candidiasis. BMJ 298: 364–375
Stevens DA, Odds FC, Scherer S (1990) Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis 12:258–266
Romano F, Ribera G, Giuliano M (1994) A study of a hospital cluster of systemic candidosis using DNA typing methods. Epidemiol Infect 112:393–398
Rangel-Frausto MS, Martin MA, Saiman L, Blumberg H, Paterson JE, Pfaller MA, Wenzel RP, and the NEMIS study group (4–7 October 1994) High prevalence of Candida spp. on hands of healthcare workers in surgical and neonatal intensive care units: a multicenter study. Presented at 34th ICAAC, Orlando, Florida, USA, Abstract J106
Rex H, Bennett JE, Sugar AM, Pappas PG, Van der Horst CM, Edwards JE, Washburn RG, Scheid M, Karchmer AW, Dine AP, Levenstein MJ, Webb CD (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325–1330
Solomon SL, Khabbaz RF, Parker RH, Bodey GP (1984) An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis 149: 98–102
Weems JJ Jr, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL (1987) Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 25:1029–1032
Lee W, Burnie JP, Matthews RC, Oppenheim BO, Damani NN (1991) Hospital outbreaks with yeasts. J Hosp Infect 18 (Suppl A): 237–249
Isenberg DD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH (1989) Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 27: 2426–2428
Pittet D, Garbino J (1995) Fungal infections in the critically ill. Curr Opin Crit Care 1:369–380
Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JEJ, Wagener MW, Yu LV (1994) Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology 101:1302–1309
Anaissie E, Solomkin JS (1994) Fungal Infection. In: Care of the surgical patient. Scientific American Medical, New York, pp 1–19
Wey SB, Motomi M, Pfaller MA, Woolson RF, Wenzel RP (1989) Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 149: 2349–2353
Martino P, Girmenia C, Venditti M, Micozzi A, Santilli S, Burgio VL, Mandelli F (1989) Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 64: 2030–2034
Martino P, Girmenia C, Micozzi A, Raccah R, Gentile G, Venditti M, Mandelli F (1993) Fungemia in patients with leukemia. Am J Med Sci 306: 225–232
Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A (1988) Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 26: 429–432
Pappu-Katikaneni H, Rao KP, Banister E (1990) Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 33: 20–23
Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital. Epidemiology, risk factors and predictors of mortality. Clin Infect Dis 15: 414–421
Giuliano M, Barza M, Jacobus NV, Gorbach SL (1987) Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother 31:202–206
Kennedy MJ, Volz PA (1985) Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouradia 23: 265–273
Samonis G, Anaissie EJ, Bodey GP (1990) Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother 34: 2420–2422
Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, Bodey GP (1993) Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 37: 51–53
Ellis CA, Spivack ML (1967) The significance of candidemia. Ann Intern Med 67:511–513
Toala P, Schroeder SA, Daly AK, Finland M (1970) Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. Arch Intern Med 126: 983–989
Edwards JE Jr (1991) Invasive Candida infections — evolution of a fungal pathogen. N Engl J Med 324:1060–1062
Bodey GP (1993) Antifungal agents. In: Bodey GP (ed) Candidiasis: Pathogenesis, diagnosis and treatment. Raven Press, New York, pp 371–406
Solomkin JS, Flohr A, Simmons RL (1982) Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. Ann Surg 195: 177–185
Medoff G (1987) Controversial areas in antifungal chemotherapy: short-course and combination therapy with amphotericin B. Rev Infect Dis 9: 403–407
Khoo SH, Bond J, Denning DW (1994) Administering amphotericin B — a practical approach. J Antimicrob Chemother 33:203–213
Lopes-Berestein G, Hopfer RL, Mehta R, Mehta K, Hersh EM, Juliano RL (1984) Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis 150: 278–283
Lopes-Berestein G, Fainstein V, Hopfer RL, Mehta K, Sullivan MP, Keating M, Juliano RL (1985) Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer. J Infect Dis 151: 704–710
Garbino J, Pittet D (1997) Candida infections in the ICU. Clin Intensive Care 8:187–200
Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, Pinczowski H, Kontoyiannis DP, Khoury P, Papadakis K, Gardner A, Raad II, Gilbreath J, Bodey GP (1996) Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med 101:170–176
Anaissie EJ, Darouiche R, Mera J, Gentry L, Abi-Said D, Bodey GP (1996) Management of invasive candidal infections: results of a prospective randomized multicenter study of fluconazole versus amphotericin B and review of literature. Clin Infect Dis 23: 964–972
Kaufmann CA, Bradley SF, Ross SC, Weber DR (1991) Hepatosplenic candidiasis. Successful treatment with fluconazole. Am J Med 91:137–141
Anaissie EJ, Bodey GP, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar A (1991) Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 91:142–150
British Society for Antimicrobial Chemotherapy (1994) Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20: 522–528
Pittet D, Anaissie E, Solomkin JS (1996) When to start antifungal therapy in the non-neutropenic critically ill? In: Vincent J-L (ed) Yearbook of Intensive Care and Emergency Medicine 1996. Springer, Berlin Heidelberg, pp 567–577
Singh N, Mieles L, Yu VL, Gayowski T (1993) Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis 17: 906–908
Mora NP, Cofer JB, Solomon H, Goldstein RM, Gonwa TA, Husberg BS, Klintmalm GB (1991) Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc 23:1528–1530
Tollemar J, Ringden O, Andersson S, Sundberg B, Ljungman P, Tyden G (1993) Randomized double-blind study of liposomal amphotericin B (AmBisome®) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 12:577–582
Kung N, Fisher N, Gunson B, Hastings M, Mutimer D (1995) Fluconazole prophylaxis for high-risk liver transplant recipients. Lancet 345:1234–1235
Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H et al. (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326: 845–851
Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H et al. (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled double-blind multicenter trial. Ann Intern Med 118: 495–503
Bodey GP, Anaissie EJ, Elting LS, Esstey E, O’Brien S, Kantarjian H (1994) Antifungal prophylaxis during remission induction therapy for acute leukemia. Fluconazole versus intravenous amphotericin B. Cancer 73: 2099–2106
Meunier F, Aoun M, Janssens M, Dekoster C, Paesmans M (1991) Chemoprophylaxis of fungal infections in granulocytopenic patients using fluconazole vs oral amphotericin B. Drug Invest 3: 258–265
Ellis ME, Clink H, Ernst P, Halim MA, Padmos A, Spence D et al. (1994) Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 13: 3–11
Author information
Authors and Affiliations
Additional information
Supported by an unrestricted educational grant from Pfizer Inc.
Rights and permissions
About this article
Cite this article
Vincent, J.L., Anaissie, E., Bruining, H. et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24, 206–216 (1998). https://doi.org/10.1007/s001340050552
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001340050552